Insight

Mohammad Jad Moussa: The new EVP ‘fissure’ challenges the dichotomy of cisplatin/platinum fitness

Photo from Mohammad Jad Moussa/X

Mar 7, 2024, 17:22

Mohammad Jad Moussa: The new EVP ‘fissure’ challenges the dichotomy of cisplatin/platinum fitness

Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on X/Twitter:

“Our Iceberg Model in Imagining the New 1L Treatment Paradigm of metastatic urothelial cancer with Matt Campbell and Omar Alhalabi.

The new EVP ‘fissure’ challenges the dichotomy of cisplatin/platinum fitness. What lurks beneath the surface?
Emerging biomarkers and treatment strategies.”

Mohammad Jad Moussa: The new EVP 'fissure' challenges the dichotomy of cisplatin/platinum fitness

Proceed to the article.
Source: Mohammad Jad Moussa/X

biomarkers cancer cancer treatment Cisplatin GU Oncology Matt Campbell MD Anderson Cancer Center metastatic urothelial cancer Mohammad Jad Moussa Omar Alhalabi OncoDaily Oncology platinum urothelial cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage